Abstract
Currently, there is no treatment to stop the progression of geographic atrophy, the advanced form of non-exudative (dry) age-related macular degeneration. Several promising therapies are being investigated in clinical trials such as antioxidants, neuroprotection agents, complement inhibitors, vascular enhancers, visual cycle modulators, and stem cell therapies. This review discusses the possible treatments that may potentially be available in the future to prevent disease progression.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 20-25 |
| Number of pages | 6 |
| Journal | Current Ophthalmology Reports |
| Volume | 2 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 1 2014 |
Keywords
- Age-related macular degeneration (AMD)
- Cell therapies
- Dry AMD
- Ophthalmology
- Treatment of geographic atrophy
ASJC Scopus subject areas
- Ophthalmology
Fingerprint Dive into the research topics of 'Treatment of Geographic Atrophy: What’s on the Horizon?'. Together they form a unique fingerprint.
Cite this
Thorell, M. R., & Rosenfeld, P. J. (2014). Treatment of Geographic Atrophy: What’s on the Horizon? Current Ophthalmology Reports, 2(1), 20-25. https://doi.org/10.1007/s40135-013-0036-y